Home > News > Pharmaceutical industry looks to commercial metathesis 13th February 2007
February 13th, 2007
Pharmaceutical industry looks to commercial metathesis 13th February 2007
Commercially available metathesis catalysts could provide drugs manufacturers with new opportunities.
Olefin metathesis is one of the most versatile ways of making carbon-carbon bonds and the process has been exploited by petrochemical, polymer, and specialty chemical industries to process simple hydrocarbons for almost 50 years.
China is expected to drive the global nanotechnology and catalysts market this year, a new report claims. Research firm RNCOS predicts that nanoscience will gain huge investment over the next twenty years, bringing about radical changes in the pharmaceutical industry.
FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014
New imaging agent provides better picture of the gut July 25th, 2014
Scientists Test Nanoparticle "Alarm Clock" to Awaken Immune Systems Put to Sleep by Cancer July 25th, 2014
Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014
Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014
Stanford team achieves 'holy grail' of battery design: A stable lithium anode - Engineers use carbon nanospheres to protect lithium from the reactive and expansive problems that have restricted its use as an anode July 27th, 2014
Iranian Scientists Produce Reusable Nanoadsorbent to Detect Sulfamide in Chicken July 27th, 2014
Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster: University of Leicester research team unlocks insights into creation of new nano-materials July 25th, 2014